Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2001 1
2002 1
2005 2
2006 1
2007 2
2008 2
2009 2
2010 4
2011 2
2012 1
2013 4
2014 4
2015 2
2016 5
2017 1
2018 4
2019 9
2020 11
2021 11
2022 6
2023 9
2024 8
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
[Chediak-Higashi syndrome].
Ortuño FJ, Fuster JL, Jerez A. Ortuño FJ, et al. Among authors: fuster jl. Med Clin (Barc). 2010 Oct 9;135(11):512-8. doi: 10.1016/j.medcli.2009.11.021. Epub 2009 Dec 30. Med Clin (Barc). 2010. PMID: 20044107 Spanish. No abstract available.
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Zanetti SR, Velasco-Hernandez T, Gutierrez-Agüera F, Díaz VM, Romecín PA, Roca-Ho H, Sánchez-Martínez D, Tirado N, Baroni ML, Petazzi P, Torres-Ruiz R, Molina O, Bataller A, Fuster JL, Ballerini P, Juan M, Jeremias I, Bueno C, Menéndez P. Zanetti SR, et al. Among authors: fuster jl. Mol Ther. 2022 Feb 2;30(2):550-563. doi: 10.1016/j.ymthe.2021.08.033. Epub 2021 Sep 1. Mol Ther. 2022. PMID: 34478871 Free PMC article.
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.
Tirado N, Fidyt K, Mansilla MJ, Garcia-Perez A, Martínez-Moreno A, Vinyoles M, Alcain J, García-Peydró M, Roca-Ho H, Fernandez-Fuentes N, Guerrero-Murillo M, Falgàs A, Velasco-Hernandez T, Bueno C, Panelli P, Mulens-Arias V, Apostolov A, Engel P, González EA, Vick B, Jeremias I, Caye-Eude A, Baruchel A, Cavé H, Genescà E, Ribera J, Díaz-Beyá M, Martínez-Sánchez MV, Fuster JL, Escudero López A, Minguillón J, Pérez-Martínez A, Ramírez-Orellana M, Torrebadell M, Díaz VM, Toribio ML, Sánchez-Martínez D, Menéndez P. Tirado N, et al. Among authors: fuster jl. J Hematol Oncol. 2025 Jul 1;18(1):69. doi: 10.1186/s13045-025-01715-0. J Hematol Oncol. 2025. PMID: 40598348 Free PMC article.
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.
Falgàs A, Lázaro-Gorines R, Zanetti SR, Rubio-Pérez L, Martínez-Moreno A, Vinyoles M, Guerrero-Murillo M, Fernández-Fuentes N, Roca-Ho H, Tirado N, Panisello C, Velasco-Hernandez T, Mayado A, Pérez-Pons A, Genescà E, Ribera JM, Ribera J, Camos M, Ramírez-Orellana M, Anguita E, Ballerini P, Fuster JL, Juan M, González-Navarro EA, Locatelli F, Stam RW, Querol S, Velasco P, Ortiz-Maldonado V, Martínez-Cibrián N, Delgado J, Orfao A, Álvarez-Vallina L, Bueno C, Menéndez P. Falgàs A, et al. Among authors: fuster jl. Blood. 2025 May 29;145(22):2599-2613. doi: 10.1182/blood.2024025440. Blood. 2025. PMID: 40090006
Spironolactone inhibits the NLRP1 inflammasome and alleviates defective erythropoiesis in Diamond-Blackfan anemia.
Rodríguez-Ruiz L, Lozano-Gil JM, Ocaña-Esparza M, Conesa-Hernández AM, Pérez-Oliva AB, Fuster JL, Jérez A, Murillo-Sanjuán L, Díaz-de-Heredia C, López-de-Hontanar G, Sevilla J, García-Moreno D, Cayuela ML, Martínez-López A, Tyrkalska SD, Mulero V. Rodríguez-Ruiz L, et al. Among authors: fuster jl. Hemasphere. 2025 Apr 17;9(4):e70131. doi: 10.1002/hem3.70131. eCollection 2025 Apr. Hemasphere. 2025. PMID: 40248129 Free PMC article. No abstract available.
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells.
Velasco-Hernandez T, Trincado JL, Vinyoles M, Closa A, Martínez-Moreno A, Gutiérrez-Agüera F, Molina O, Rodríguez-Cortez VC, Ximeno-Parpal P, Fernández-Fuentes N, Petazzi P, Beneyto-Calabuig S, Velten L, Romecin P, Casquero R, Abollo-Jiménez F, de la Guardia RD, Lorden P, Bataller A, Lapillonne H, Stam RW, Vives S, Torrebadell M, Fuster JL, Bueno C, Sarry JE, Eyras E, Heyn H, Menéndez P. Velasco-Hernandez T, et al. Among authors: fuster jl. Hemasphere. 2024 Feb 26;8(2):e45. doi: 10.1002/hem3.45. eCollection 2024 Feb. Hemasphere. 2024. PMID: 38435427 Free PMC article.
Identification of copy-number variants in patients with overgrowth disorders.
Parra A, Tenorio-Castano J, Nevado J, Cazalla M, Miranda-Alcaraz L, Gallego-Zazo N, Silván C, Arias P, Pozo-Román J, Ballesta-Martínez MJ, Guillén-Navarro E, Arroyo I, Lotersztein V, Cosentino V, González-Meneses A, Galán E, Rosell J, Ramos F; Spanish OverGrowth Registry Initiative; Lapunzina P. Parra A, et al. Clin Genet. 2024 Nov;106(5):614-624. doi: 10.1111/cge.14596. Epub 2024 Aug 1. Clin Genet. 2024. PMID: 39091142
CALRins5-mediated clonal hematopoiesis causes severe hemolytic anemia in a female PGK1Ser320Asn carrier.
Morales ML, Cano H, de la Morena-Barrio B, Vives-Corrons JL, Cuenca-Zamora EJ, Garrido-Rodríguez P, Bento C, Pereira J, Martínez Nieto J, Chen-Liang TH, Fuster JL, Caracena S, Lozano ML, Teruel-Montoya R, Corral J, Ferrer-Marín F. Morales ML, et al. Among authors: fuster jl. Blood Cancer J. 2025 Feb 1;15(1):8. doi: 10.1038/s41408-025-01216-w. Blood Cancer J. 2025. PMID: 39893164 Free PMC article. No abstract available.
80 results